Deutsche Bank Ag\ Nex Immune, Inc. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.61 - $4.68 $15,422 - $44,829	-9,579 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.79 - $4.65 $2,040 - $5,301	-1,140 Reduced 10.64%	9,579 $40,000
Q4 2021 Feb 11, 2022	BUY	$4.11 - $15.13 $2,342 - $8,624	570 Added 5.62%	10,719 $49,000
Q3 2021 Nov 04, 2021	BUY	$10.32 - $16.9 $64,396 - $105,455	6,240 Added 159.63%	10,149 $154,000
Q2 2021 Aug 11, 2021	SELL	$14.98 - $23.89 $1,872 - $2,986	-125 Reduced 3.1%	3,909 $64,000
Q1 2021 May 13, 2021	BUY	$17.95 - $25.91 $72,410 - $104,520	4,034 New	4,034 $76,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $5.56M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.